Jim Simons Selecta Biosciences Inc Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 553,600 shares of SELB stock, worth $465,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

553,600

Previous 517,800 6.91%

Holding current value

$465,024

Previous $357,000 0.84%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.62 - $0.85 $22,196 - $30,430	35,800 Added 6.91%	553,600 $360,000
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.35 $139,494 - $281,070	-208,200 Reduced 28.68%	517,800 $357,000
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $282,032 - $340,097	-276,502 Reduced 27.58%	726,000 $770,000
Q2 2023 Aug 11, 2023	SELL	$1.04 - $1.4 $73,408 - $98,819	-70,585 Reduced 6.58%	1,002,502 $1.12 Million
Q1 2023 May 12, 2023	SELL	$1.15 - $1.89 $174,533 - $286,841	-151,768 Reduced 12.39%	1,073,087 $1.49 Million

Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.6 $306,964 - $511,608	319,755 Added 35.33%	1,224,855 $1.38 Million
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $421,232 - $823,461	316,716 Added 53.83%	905,100 $1.48 Million
Q2 2022 Aug 12, 2022	SELL	$0.67 - $1.4 $604,350 - $1.26 Million	-902,016 Reduced 60.52%	588,384 $771,000
Q1 2022 May 13, 2022	BUY	$1.23 - $3.31 $1.25 Million - $3.36 Million	1,014,200 Added 212.98%	1,490,400 $1.83 Million
Q4 2021 Feb 11, 2022	BUY	$2.89 - $4.43 $618,460 - $948,019	214,000 Added 81.62%	476,200 $1.55 Million
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.62 $557,931 - $767,155	-166,051 Reduced 38.77%	262,200 $1.09 Million
Q2 2021 Aug 13, 2021	BUY	$2.82 - $5.01 $405,377 - $720,192	143,751 Added 50.53%	428,251 $1.79 Million
Q1 2021 May 13, 2021	SELL	$2.92 - $5.07 $2.01 Million - $3.48 Million	-686,733 Reduced 70.71%	284,500 $1.29 Million
Q4 2020 Feb 10, 2021	BUY	$1.64 - $3.42 $778,791 - $1.62 Million	474,873 Added 95.67%	971,233 $2.94 Million
Q3 2020 Nov 13, 2020	SELL	$2.18 - $2.84 $1.4 Million - $1.82 Million	-640,780 Reduced 56.35%	496,360 $1.23 Million
Q2 2020 Aug 13, 2020	SELL	$1.83 - $4.06 $618,077 - $1.37 Million	-337,747 Reduced 22.9%	1,137,140 $3.23 Million
Q1 2020 May 14, 2020	BUY	$1.5 - $4.52 $900,940 - $2.71 Million	600,627 Added 68.7%	1,474,887 $3.55 Million
Q4 2019 Feb 13, 2020	BUY	$1.32 - $2.47 $316,654 - $592,528	239,890 Added 37.82%	874,260 $2.08 Million
Q3 2019 Nov 13, 2019	BUY	$1.6 - $2.08 $260,592 - $338,769	162,870 Added 34.54%	634,370 $1.11 Million
Q2 2019 Aug 12, 2019	BUY	$1.79 - $3.05 $418,502 - $713,090	233,800 Added 98.36%	471,500 $844,000
Q1 2019 May 14, 2019	BUY	$1.47 - $3.06 $185,220 - $385,560	126,000 Added 112.8%	237,700 $563,000
Q4 2018 Feb 13, 2019	BUY	$2.66 - $15.93 $297,122 - $1.78 Million	111,700 New	111,700 $297,000

Others Institutions Holding SELB

# of Institutions

Shares Held

41.4M

Call Options Held

16.8K

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account